Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06367218Recruiting
Randomised, open-label trial of esketamine in pulmonary nodules (SPN) (4 arms), sponsored by Tongji Hospital. Primary endpoint: Lung function 30 days after surgery. Started Oct 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06367218.